Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.410
-0.070 (-2.01%)
At close: Apr 28, 2026, 4:00 PM EDT
3.410
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:37 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.80 billion as of April 28, 2026. Its market cap has decreased by -0.72% in one year.
Market Cap
1.80B
Enterprise Value
1.14B
1-Year Change
-0.72%
Ranking
Category
Stock Price
$3.41
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.80B, a decrease of -64.51%. That is a compound annual growth rate of -18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.84B | -13.65% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.92B |
| AnaptysBio | 1.91B |
| Galapagos NV | 1.89B |
| Vericel | 1.88B |
| Pharvaris | 1.88B |
| Taysha Gene Therapies | 1.86B |
| Syndax Pharmaceuticals | 1.85B |
| Palvella Therapeutics | 1.84B |